Effects of sprint interval or combined aerobic and resistance training on myokines in overweight women with type 2 diabetes: A randomized controlled trial

Life Sci. 2019 Jan 15:217:101-109. doi: 10.1016/j.lfs.2018.11.062. Epub 2018 Nov 30.

Abstract

Our primary aim was to assess the effects of two different training modalities: sprint interval training (SIT) or combined aerobic and resistance training (A + R) on circulating myokines related to metabolic profile and adiposity in type 2 diabetes (T2D). Fifty-two overweight women with T2D [55 ± 6 yrs., BMI 28.9 ± 4.1 kg/m2, HbA1c 9.4 ± 0.82% (79 mmol/mol)] were randomized to SIT (n = 17), A + R training (n = 17) or control (n = 18) for 10 weeks. Myokines, metabolic outcomes, body composition and cardiorespiratory fitness were assessed at baseline and 48 hours after the last training session/control period. Relationships between myokines and other variables were investigated via linear regression models. Completion rate was 81%. There was no effect of either exercise modality on any myokine. Interlukin-15 decreased over time irrespective of group assignment (p = 0.02). Aerobic capacity (p = 0.01), fasting glucose (p = 0.03) and HbA1c (p = 0.006) improved significantly and similarly in both exercise groups compared to controls. Insulin (p = 0.02), weight (p = 0.020, body max index (BMI) (p = 0.01) decreased significantly over time irrespective of group. Changes in myokines were unrelated to changes in body composition or metabolic profile. Neither SIT or A + R training altered myokines measured 48 h after exercise in T2D, despite improving aerobic capacity and glucose homeostasis relative to controls. Future studies are needed to elucidate the time course and clinical relevance of putative myokine responses to exercise in this and other cohorts.

Keywords: Combined Aerobic and Resistance Training (A + R); Myokines; Short sprint interval training (SIT); Type 2 diabetes.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Angiopoietin-Like Protein 4 / blood
  • Body Composition
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / therapy*
  • Exercise
  • Exercise Therapy / methods*
  • Exercise Tolerance
  • Female
  • Fibroblast Growth Factors / blood
  • Fibronectins / blood
  • High-Intensity Interval Training / methods*
  • Humans
  • Interleukin-15 / blood
  • Interleukin-6 / blood
  • Metabolome
  • Middle Aged
  • Osteonectin / blood
  • Overweight / blood*
  • Overweight / complications
  • Overweight / metabolism
  • Overweight / therapy*
  • Resistance Training / methods*

Substances

  • ANGPTL4 protein, human
  • Angiopoietin-Like Protein 4
  • FNDC5 protein, human
  • Fibronectins
  • Interleukin-15
  • Interleukin-6
  • Osteonectin
  • SPARC protein, human
  • fibroblast growth factor 21
  • Fibroblast Growth Factors